Ischaemic heart failure remains a major contributor to cardiovascular morbidity and mortality, requiring a multidimensional treatment approach that extends beyond symptom control. Rapid advances in pharmacotherapy, device therapy, and revascularization strategies are reshaping how clinicians manage these patients.

In this session, Dr Deepak Puri will review the latest developments in the comprehensive management of ischaemic heart failure. The discussion will cover contemporary guideline-directed medical therapy, the role of revascularization, device-based interventions, and strategies for long-term risk reduction. The focus will be on translating evolving evidence into practical clinical decisions that improve patient outcomes.